Who is sponsoring NCT03583008?

NCT03583008 is sponsored by University of Massachusetts, Worcester.

What drugs are being tested in NCT03583008?

Interventions in NCT03583008: Anticoagulation (AC) Intervention--Academic Detailing, Anticoagulation (AC) Intervention--Prescribing Practices.

What condition does NCT03583008 study?

NCT03583008 studies Atrial Fibrillation, Prescribing Practices, Anticoagulants.

Is NCT03583008 still recruiting?

NCT03583008 is currently completed. Last updated 21 March 2019.

Last reviewed 2019-03-21 · How we verify

NCT03583008: SUPPORT-AF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF

Completed NA Last updated 21 March 2019

What this trial tests

NA trial testing Anticoagulation (AC) Intervention--Academic Detailing in Atrial Fibrillation in 112 participants. Completed in 1 March 2019.

Timeline

11 June 2018

Primary endpoint
1 February 2019

1 March 2019

Quick facts

Lead sponsor	University of Massachusetts, Worcester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	112
Start date	11 June 2018
Primary completion	1 February 2019
Estimated completion	1 March 2019
Sites	1 location across United States

Drugs / interventions tested

Anticoagulation (AC) Intervention--Academic Detailing
Anticoagulation (AC) Intervention--Prescribing Practices

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →
Prescribing Practices — all drugs for Prescribing Practices →
Anticoagulants — all drugs for Anticoagulants →

Sponsor

University of Massachusetts, Worcester

Who can join

18 and older, any sex, with Atrial Fibrillation or Prescribing Practices. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SUPPORT-AF study aims to improve rates of anticoagulation (AC) in atrial fibrillation (AF) patients by developing and delivering supportive tools and educational materials to providers treating patients with AF. The investigators hypothesize that AC percentage will increase among providers receiving tools and educational content.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

SUPPORT-AF II: Supporting Use of Anticoagulants Through Provider Profiling of Oral Anticoagulant Therapy for Atrial Fibrillation: A Cluster-Randomized Study of Electronic Profiling and Messaging Combined With Academic Detailing for Providers Making Decisions About Anticoagulation
Kapoor A, Amroze A, Vakil F, Crawford S, et al · · 2020 · cited 27× · PMID 32063041 · DOI 10.1161/circoutcomes.119.005871
Assessing Anticoagulation Management and Shared Decision-Making Documentation from Providers Participating in the SUPPORT-AF Study
Hoque L, Amroze A, Gilvaz V, Abraham S, et al · · 2019 · DOI 10.21203/rs.2.13133/v1

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other University of Massachusetts, Worcester trials

Trials by the same sponsor.

NCT07431528 — Dementia and Storytelling in Vietnam · NA · not yet recruiting
NCT07060664 — Study on Outcomes of Proximal Humerus Fractures · NA · not yet recruiting
NCT07520110 — Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis · Phase 3 · not yet recruiting
NCT06100809 — Does Fatigue Coaching Improve Functioning and Fatigue in Resident Night Shifts · NA · not yet recruiting
NCT06246539 — Impact of a Virtual Reality-based Mindfulness Program on Clinician Wellness · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03583008 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Worcester
Last refreshed: 21 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03583008.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing